Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Imetelstat
1. Grn163l
2. F60ne4xb53
3. 5'-(o-(2-hydroxy-3-((1-oxohexadecyl)amino)propyl) Hydrogen Phosphorothioate)-d(3'-amino-3'-deoxy-p-thio)(t-a-g-g-g-t-t-a-g-a-c-a-a)
4. Grn163l Peptide
5. Imetelstat [inn]
6. Imetelstat [usan]
7. Imetelstat [who-dd]
8. Unii-f60ne4xb53
9. Grn 163l
10. Grn-163l
| Molecular Weight | 4610 g/mol |
|---|---|
| Molecular Formula | C148H211N68O53P13S13 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 45 |
| Hydrogen Bond Acceptor Count | 107 |
| Rotatable Bond Count | 95 |
| Exact Mass | 4607.8897749 g/mol |
| Monoisotopic Mass | 4606.8864201 g/mol |
| Topological Polar Surface Area | 2010 Ų |
| Heavy Atom Count | 295 |
| Formal Charge | 0 |
| Complexity | 11900 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 39 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in leukemia (lymphoid) and solid tumors.
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
GRN163L has been characterized preclinically and shown to inhibit telomerase in human tumor cells of many cancer types. It targets the template region, or active site, of telomerase. GRN163L does not exhibit antisense activity (binding to messenger RNA), but rather directly bind to the RNA component of telomerase at the active site of the enzyme, thereby acting like a conventional pharmaceutical drug. Inhibiting telomerase activity should result in telomere shortening and therefore cause aging and death of cancer cells.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
23
PharmaCompass offers a list of Imetelstat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imetelstat manufacturer or Imetelstat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imetelstat manufacturer or Imetelstat supplier.
PharmaCompass also assists you with knowing the Imetelstat API Price utilized in the formulation of products. Imetelstat API Price is not always fixed or binding as the Imetelstat Price is obtained through a variety of data sources. The Imetelstat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imetelstat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imetelstat, including repackagers and relabelers. The FDA regulates Imetelstat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imetelstat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Imetelstat supplier is an individual or a company that provides Imetelstat active pharmaceutical ingredient (API) or Imetelstat finished formulations upon request. The Imetelstat suppliers may include Imetelstat API manufacturers, exporters, distributors and traders.
Imetelstat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imetelstat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imetelstat GMP manufacturer or Imetelstat GMP API supplier for your needs.
A Imetelstat CoA (Certificate of Analysis) is a formal document that attests to Imetelstat's compliance with Imetelstat specifications and serves as a tool for batch-level quality control.
Imetelstat CoA mostly includes findings from lab analyses of a specific batch. For each Imetelstat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imetelstat may be tested according to a variety of international standards, such as European Pharmacopoeia (Imetelstat EP), Imetelstat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imetelstat USP).
